Effects of GP IIb/IIIa receptor antagonists on the activating clotting time of heparinized blood.
Himber
J
J
Burckien
L
L
Steiner
B
B
D000077284:Abciximab; D000085:Acetates / Q000494:pharmacology; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D000925:Anticoagulants / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects*; D006405:Hematology / Q000295:instrumentation; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000494:pharmacology; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013997:Time Factors; D014443:Tyrosine / Q000031:analogs & derivatives / Q000494:pharmacology; D014914:Whole Blood Coagulation Time
D000085:Acetates; D000911:Antibodies, Monoclonal; D000925:Anticoagulants; D007140:Immunoglobulin Fab Fragments; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D014443:Tyrosine; D006493:Heparin; C084062:lamifiban; D000077284:Abciximab